Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Telephone Reminder to Increase Appointment Rates

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04707599
Recruitment Status : Completed
First Posted : January 13, 2021
Last Update Posted : January 15, 2021
Sponsor:
Information provided by (Responsible Party):
Sorlandet Hospital HF

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

Missed appointments to outpatient substance use treatment are common and costly and can have a negative effect on the health of patients.

In this quasi-experimental study, the investigators used an on-off design to examine whether a reminder "plus" intervention (telephone call from therapist before first appointment) would increase attendance and improve cancellation and rebooking practices. Secondary outcomes included satisfaction with treatment and intention to complete the treatment program.


Condition or disease Intervention/treatment Phase
Reminder Systems Substance-Related Disorders Other: Reminder plus (telephone call from therapist) Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 147 participants
Allocation: Non-Randomized
Intervention Model: Sequential Assignment
Intervention Model Description: Quasi-experimental with an OFF-ON design
Masking: Single (Participant)
Masking Description: The aim of the study was presented to all participants (to examine dropout/ retention from treatment), but patients were blinded to information about the phase comparison (i.e., that there was a pretreatment telephone Call from therapist in one phase and not in the other).
Primary Purpose: Health Services Research
Official Title: Reducing the Rate of Missed Appointments in an Outpatient Substance Use Treatment Clinic in Norway
Actual Study Start Date : April 1, 2015
Actual Primary Completion Date : December 31, 2016
Actual Study Completion Date : December 31, 2016
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
No Intervention: OFF intervention
No reminder plus (telephone reminder from therapist) but standard test message reminder (SMS) from second admission
Experimental: ON intervention
Reminder plus (telephone reminder from therapist) AND standard test message reminder (SMS) from second admission
 Other: Reminder plus (telephone call from therapist)
Reminder plus (telephone call from therapist)


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Attendance rate [ Time Frame: Up to 10 treatment sessions, estimated average timeframe = 3 months ]
    Attendance rate at first admission and during 10 outpatient sessions


Secondary Outcome Measures :
  1. Dropout rate [ Time Frame: Up to 10 treatment sessions, estimated average timeframe = 3 months ]
    Dropout rate within 10 sessions - measured as formal discharge and/or "technical discharge" (3x no-shows)

  2. Cancellation / rebooking rate [ Time Frame: Up to 10 treatment sessions, estimated average timeframe = 3 months ]
    Examine difference in cancellation / rebooking rate between the two conditions. Data was collected from administrative patient records.


Other Outcome Measures:
  1. Treatment satisfaction [ Time Frame: First week ]
    Treatment satisfaction - measured with the Session Rating Scale (scale 0 - 40, higher scores means higher satisfaction)

  2. Intention to complete treatment [ Time Frame: First week ]
    Intention to complete treatment program. Self-developed measured based on the Theory of Planned Behavior. Scale 1 - 7, higher scores means higher intention to Complete treatment).


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Newly referred patient
  • > 18 years
  • Diagnosis: Substance related disorder

Exclusion Criteria:

  • Patients who are unable to understand or score the survey due to cognitive or language barriers
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04707599


Locations
Layout table for location information
Norway
Addiction Unit - Sørlandet Hospital
Arendal, Agder, Norway
Addiction Unit - Sørlandet Hospital
Kristiansand, Agder, Norway, 4600
Sponsors and Collaborators
Sorlandet Hospital HF
Investigators
Layout table for investigator information
Principal Investigator: John-Kåre Vederhus, PhD Sørlandet Hospital
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Sorlandet Hospital HF
ClinicalTrials.gov Identifier: NCT04707599    
Other Study ID Numbers: 005004 - 2014/2225
First Posted: January 13, 2021    Key Record Dates
Last Update Posted: January 15, 2021
Last Verified: January 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders